XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 611.9 $ 770.7
Trade and other receivables, net of allowance of $78.2 million and $72.2 million, as of March 31, 2022 and December 31, 2021, respectively 1,372.7 1,446.0
Income tax receivable 32.0 30.0
Short-term contract assets, net 360.6 318.9
Prepaid expenses and other current assets 295.7 264.7
Total current assets 2,672.9 2,830.3
Property and equipment, net 192.4 194.6
Goodwill 2,084.3 2,081.9
Intangible assets, net 908.1 922.2
Equity method investments 654.4 641.3
Deferred tax assets 65.0 65.5
Non-current operating lease assets 398.7 413.5
Other non-current assets 780.3 741.1
Total assets 7,756.1 7,890.4
Current liabilities:    
Short-term borrowings and current portion of long-term debt 43.3 42.4
Accounts payable and accrued expenses 1,083.5 1,106.2
Accrued compensation 840.1 976.3
Income tax payable 136.9 105.1
Other current liabilities 215.5 204.5
Total current liabilities 2,319.3 2,434.5
Long-term debt, net 3,215.9 3,220.5
Deferred tax liabilities 36.3 48.7
Non-current operating lease liabilities 377.8 394.6
Other non-current liabilities 268.3 343.5
Total liabilities 6,217.6 6,441.8
Commitments and contingencies
Shareholders' equity:    
Ordinary shares, nominal value $0.10 per share, 800,000,000 shares authorized; 225,445,522 and 223,709,308 shares issued and outstanding as of March 31, 2022 and at December 31, 2021, respectively 22.6 22.4
Additional paid-in capital 2,880.0 2,896.6
Accumulated deficit (1,232.7) (1,278.2)
Accumulated other comprehensive loss (132.2) (193.0)
Total equity attributable to the Company 1,537.7 1,447.8
Non-controlling interests 0.8 0.8
Total equity 1,538.5 1,448.6
Total liabilities and shareholders' equity $ 7,756.1 $ 7,890.4